Provectus BiopharmaceuticalsPVCT 
$0.13-0.78%24h
-0.78%24h
Global rank23595
Market cap$53.70M
Change 7d2.40%
YTD Performance50.59%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Provectus Biopharmaceuticals (PVCT)
As of December 2024, Provectus Biopharmaceuticals has a market cap of $53.70M. This makes Provectus Biopharmaceuticals the world's 23595th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Provectus Biopharmaceuticals from 1997 to 2024
-
Value:-
Market cap history of Provectus Biopharmaceuticals from 1997 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $57.26M | 42.18% |
| 2023 | $40.27M | -11.11% |
| 2022 | $45.31M | 96.36% |
| 2021 | $23.07M | -5.17% |
| 2020 | $24.33M | -7.94% |
| 2019 | $26.43M | 26.00% |
| 2018 | $20.98M | -39.02% |
| 2017 | $34.40M | 310.00% |
| 2016 | $8.39M | -94.87% |
| 2015 | $163.61M | -51.25% |
| 2014 | $335.62M | -66.80% |
| 2013 | $1.01B | 330.36% |
| 2012 | $234.93M | -30.86% |
| 2011 | $339.81M | -13.83% |
| 2010 | $394.35M | 3.30% |
| 2009 | $381.77M | -1.09% |
| 2008 | $385.96M | -46.51% |
| 2007 | $721.58M | 44.54% |
| 2006 | $499.23M | 32.22% |
| 2005 | $377.57M | 36.36% |
| 2004 | $276.88M | -34.65% |
| 2003 | $423.72M | 260.71% |
| 2002 | $117.47M | -99.96% |
| 2001 | $264.30B | 20.00% |
| 2000 | $220.25B | -65.00% |
| 1999 | $629.28B | 0.00% |
| 1998 | $629.28B | 0.00% |
| 1997 | $629.28B | - |
PVCT Market Cap Today is $53.70M -0.78% - 14 Dec 2024
View largest stocks by market cap 
